R. Read

发表

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

R. Wunderink, M. Niederman, T. Welte, 2017, European Respiratory Journal.

Guidelines for the management of adult lower respiratory tract infections--summary.

T. Schaberg, A. Ortqvist, F. Blasi, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia

R. Wunderink, M. Niederman, T. Welte, 2018, ERJ Open Research.

ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial

M. Shankar-Hari, Dave Singh, A. Gordon, 2020, Trials.

Clinical Efficacy of Moxifloxacin Versus Comparator Therapies for Community-Acquired Pneumonia Caused by Legionella spp.

P. Arvis, J. Garau, A. Fritsch, 2010, Journal of chemotherapy.

ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training

F. Blasi, G. Rohde, A. Torres, 2018, Breathe.

Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial

Philip Smith, J. Raftery, K. Hood, 2021, The Lancet.

The management of infective gastroenteritis in adults. A consensus statement by an expert panel convened by the British Society for the Study of Infection.

D. Nathwani, R. Finch, P. Moss, 1996, The Journal of infection.

The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults.

N. Beeching, R. Heyderman, Jonathan Cohen, 2016, The Journal of infection.

Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation.

W. Lim, A. Montgomery, D. Whynes, 2015, Health technology assessment.

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Scott M Elliott, J. Haughney, V. Libri, 2021, The Lancet.

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

A. Mann, N. Ferguson, C. Hopkins, 2022, Nature Medicine.

Controlled human infection with Neisseria lactamica in late pregnancy to measure horizontal transmission and microbiome changes in mother–neonate pairs: a single-arm interventional pilot study protocol

A. Theodosiou, C. Jones, D. Cleary, 2022, BMJ Open.

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

V. Libri, S. Royal, G. Screaton, 2022, The Lancet Respiratory Medicine.

Guidelines for the management of adult lower respiratory tract infections ‐ Full version

T. Schaberg, A. Ortqvist, F. Blasi, 2011, Clinical Microbiology and Infection.

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

J. Haughney, V. Libri, J. Nguyen-Van-Tam, 2023, Journal of Infection.

Hospital management of adults with severe acute respiratory syndrome (SARS) if SARS re-emerges—updated 10 February 2004

R. Read, W. S. Lim, S. Anderson, 2004, Journal of Infection.

[The JRS guidelines for the management of community acquired pneumonia in adults].

J. Macfarlane, A. Hill, M. Levy, 2007, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

V. Libri, G. Screaton, J. Nguyen-Van-Tam, 2023, Journal of Infection.

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)

W. Lim, S. Brett, J. Nguyen-Van-Tam, 2010, Thorax.

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

W. Lim, J. Macfarlane, R. Read, 2009, Thorax.

A Questionnaire-based Study Exploring Participant Perspectives in a Perinatal Human Challenge Trial.

A. Theodosiou, R. Dorey, C. Jones, 2023, The Pediatric infectious disease journal.

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A Randomised Controlled Trial

J. Nguyen-Van-Tam, P. Aley, M. Snape, 2023, Journal of Infection.

Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice

M. Teare, R. Read, General Practitioner, 2012, BMJ Open.

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

R. George, H. Roberts, M. Woodhead, 2009, Thorax.

Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK

W. Lim, S. Brett, J. Nguyen-Van-Tam, 2014, Epidemiology and Infection.

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

R. George, H. Roberts, M. Woodhead, 2009, Thorax.